Literature DB >> 14978097

Toward a definition of self: proteomic evaluation of the class I peptide repertoire.

Heather D Hickman1, Angela D Luis, Rico Buchli, Steven R Few, Muthuraman Sathiamurthy, Rodney S VanGundy, Christopher F Giberson, William H Hildebrand.   

Abstract

MHC class I molecules present host- and pathogen-derived peptides for immune surveillance. Much attention is given to the search for viral and tumor nonself peptide epitopes, yet the question remains, "What is self?" Analyses of Edman motifs and of small sets of individual peptides suggest that the class I self repertoire consists of thousands of different peptides. However, there exists no systematic characterization of this self-peptide backdrop, causing the definition of class I-presented self to remain largely hypothetical. To better understand the breadth and nature of self proteins sampled by class I HLA, we sequenced >200 endogenously loaded HLA-B*1801 peptides from a human B cell line. Peptide-source proteins, ranging from actin-related protein 6 to zinc finger protein 147, possessed an assortment of biological and molecular functions. Major categories included binding proteins, catalytic proteins, and proteins involved in cell metabolism, growth, and maintenance. Genetically, peptides encoded by all chromosomes were presented. Statistical comparison of proteins presented by class I vs the human proteome provides empiric evidence that the range of proteins sampled by class I is relatively unbiased, with the exception of RNA-binding proteins that are over-represented in the class I peptide repertoire. These data show that, in this cell line, class I-presented self peptides represent a comprehensive and balanced summary of the proteomic content of the cell. Importantly, virus- and tumor-induced changes in virtually any cellular compartment or to any chromosome can be expected to be presented by class I molecules for immune recognition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978097     DOI: 10.4049/jimmunol.172.5.2944

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  The origin of proteasome-inhibitor resistant HLA class I peptidomes: a study with HLA-A*68:01.

Authors:  Noel García-Medel; Alejandro Sanz-Bravo; Eilon Barnea; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2011-10-03       Impact factor: 5.911

2.  A novel vascular targeting strategy for brain-derived endothelial cells using a TCR mimic antibody.

Authors:  Raktima Bhattacharya; Yan Xu; Md Ashequr Rahman; Pierre-Olivier Couraud; Ignacio A Romero; Babette B Weksler; Jon A Weidanz; Ulrich Bickel
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

3.  Autophagy promotes MHC class II presentation of peptides from intracellular source proteins.

Authors:  Jörn Dengjel; Oliver Schoor; Rainer Fischer; Michael Reich; Marianne Kraus; Margret Müller; Katharina Kreymborg; Florian Altenberend; Jens Brandenburg; Hubert Kalbacher; Roland Brock; Christoph Driessen; Hans-Georg Rammensee; Stefan Stevanovic
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-13       Impact factor: 11.205

4.  The design and implementation of the immune epitope database and analysis resource.

Authors:  Bjoern Peters; John Sidney; Phil Bourne; Huynh-Hoa Bui; Soeren Buus; Grace Doh; Ward Fleri; Mitch Kronenberg; Ralph Kubo; Ole Lund; David Nemazee; Julia V Ponomarenko; Muthu Sathiamurthy; Stephen P Schoenberger; Scott Stewart; Pamela Surko; Scott Way; Steve Wilson; Alessandro Sette
Journal:  Immunogenetics       Date:  2005-05-14       Impact factor: 2.846

5.  Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides.

Authors:  Daniel Gebreselassie; Hans Spiegel; Stanislav Vukmanovic
Journal:  Hum Immunol       Date:  2006-09-20       Impact factor: 2.850

Review 6.  Recent progress in adjuvant discovery for peptide-based subunit vaccines.

Authors:  Fazren Azmi; Abdullah Al Hadi Ahmad Fuaad; Mariusz Skwarczynski; Istvan Toth
Journal:  Hum Vaccin Immunother       Date:  2013-12-03       Impact factor: 3.452

Review 7.  Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands.

Authors:  Gabor Mester; Vanessa Hoffmann; Stefan Stevanović
Journal:  Cell Mol Life Sci       Date:  2011-03-09       Impact factor: 9.261

8.  Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity.

Authors:  Mehdi Tafti; Gert J Lammers; Yves Dauvilliers; Sebastiaan Overeem; Geert Mayer; Jacek Nowak; Corinne Pfister; Valérie Dubois; Jean-François Eliaou; Hans-Peter Eberhard; Roland Liblau; Aleksandra Wierzbicka; Peter Geisler; Claudio L Bassetti; Johannes Mathis; Michel Lecendreux; Ramin Khatami; Raphaël Heinzer; José Haba-Rubio; Eva Feketeova; Christian R Baumann; Zoltán Kutalik; Jean-Marie Tiercy
Journal:  Sleep       Date:  2016-03-01       Impact factor: 5.849

9.  Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes.

Authors:  Curtis P McMurtrey; Alina Lelic; Paolo Piazza; Ayan K Chakrabarti; Eric J Yablonsky; Angela Wahl; Wilfried Bardet; Annette Eckerd; Robert L Cook; Rachael Hess; Rico Buchli; Mark Loeb; Charles R Rinaldo; Jonathan Bramson; William H Hildebrand
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

10.  Systematic characterisation of cellular localisation and expression profiles of proteins containing MHC ligands.

Authors:  Agnieszka S Juncker; Mette V Larsen; Nils Weinhold; Morten Nielsen; Søren Brunak; Ole Lund
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.